$IMUN Research report! IMMUNOVATIVE, INC.
Post# of 165
$IMUN Research report!
IMMUNOVATIVE, INC. The Only Way to Treat Cancer | |
Rob Goldman August 3, 2012 | |
IMMUNOVATIVE, INC. (OTC:BB - IMUN - $0.22) | |
Price Target: $1.70 | Rating: Speculative Buy |